NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

I know it’s 4 months. Obviously I think if we are still waiting in March that the company without any news on the trial that will mean that the company is going beyond the 3 years “active phase” and extending the “follow-up” phase. I’m expecting that we hear an update before March, as in February the latest — before then. If we are not told a thing before March, I’m going to start getting annoyed, as we should be told how long they plan to keep the trial running.

Consent form.

“The clinical trial will consist of three phases: the initial evaluation phase (also known as the screening phase), the active treatment phase, and the follow-up phase. During the evaluation phase you will undergo some testing noted below to indicate whether you can participate. The next phase, the active treatment phase, is when patients are treated with DCVax-L or placebo. During this phase, which lasts up to 36 months, you will be asked to return to the clinic once every two months for MRIs and other tests as outlined below under Study Visits Procedures to determine how you are doing. During the follow-up phase, which starts after the 36 months is completed or after you leave the trial for any reason, you and/or a designated contact will be contacted every third month to collect medical history including data on long-term progression or re-growth of your brain cancer as well as survival data.. Please read the section titled Follow-Up Information.”